Perrigo Pre-Tax Profit Margin 2010-2023 | PRGO
Perrigo Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
2023-12-31 | $4.66B | $-0.01B | -0.17% |
2023-09-30 | $4.65B | $0.03B | 0.69% |
2023-06-30 | $4.63B | $0.01B | 0.19% |
2023-03-31 | $4.56B | $-0.12B | -2.68% |
2022-12-31 | $4.45B | $-0.14B | -3.12% |
2022-09-30 | $4.40B | $-0.12B | -2.61% |
2022-06-30 | $4.35B | $0.28B | 6.40% |
2022-03-31 | $4.20B | $0.23B | 5.45% |
2021-12-31 | $4.14B | $0.26B | 6.26% |
2021-09-30 | $4.09B | $0.13B | 3.28% |
2021-06-30 | $4.05B | $-0.21B | -5.11% |
2021-03-31 | $4.02B | $-0.03B | -0.85% |
2020-12-31 | $4.09B | $0.01B | 0.15% |
2020-09-30 | $3.39B | $0.06B | 1.89% |
2020-06-30 | $3.58B | $0.11B | 3.16% |
2020-03-31 | $3.78B | $0.12B | 3.28% |
2019-12-31 | $3.87B | $0.15B | 3.82% |
2019-09-30 | $4.71B | $0.41B | 8.68% |
2019-06-30 | $4.65B | $0.23B | 5.01% |
2019-03-31 | $4.69B | $0.26B | 5.57% |
2018-12-31 | $4.73B | $0.29B | 6.15% |
2018-09-30 | $4.82B | $0.22B | 4.54% |
2018-06-30 | $4.92B | $0.43B | 8.68% |
2018-03-31 | $4.97B | $0.30B | 5.96% |
2017-12-31 | $4.95B | $0.28B | 5.68% |
2017-09-30 | $4.99B | $-1.50B | -29.94% |
2017-06-30 | $5.03B | $-3.53B | -70.17% |
2017-03-31 | $5.13B | $-4.26B | -83.11% |
2016-12-31 | $5.28B | $-4.85B | -91.80% |
2016-09-30 | $2.93B | $-3.54B | -120.94% |
2016-06-30 | $2.94B | $-1.34B | -45.71% |
2015-12-31 | $1.22B | $0.01B | 0.82% |
2015-09-30 | $3.31B | $0.43B | 13.01% |
2014-12-31 | $3.03B | $0.26B | 8.49% |
2014-09-30 | $2.94B | $0.06B | 2.01% |
2013-12-31 | $2.83B | $0.20B | 7.20% |
2013-09-30 | $2.74B | $0.46B | 16.92% |
2012-12-31 | $2.43B | $0.42B | 17.36% |
2012-09-30 | $2.39B | $0.42B | 17.60% |
2011-12-31 | $2.26B | $0.35B | 15.34% |
2011-09-30 | $2.14B | $0.32B | 15.18% |
2010-12-31 | $1.90B | $0.31B | 16.29% |
2010-09-30 | $1.76B | $0.28B | 15.96% |
2009-12-31 | $1.62B | $0.22B | 13.80% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.103B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
Stryker (SYK) | United States | $127.230B | 30.47 |
Medtronic (MDT) | Ireland | $113.715B | 16.10 |
Boston Scientific (BSX) | United States | $109.372B | 34.84 |
EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
ResMed (RMD) | United States | $32.315B | 30.34 |
Terumo (TRUMY) | Japan | $26.460B | 37.37 |
Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
Baxter (BAX) | United States | $17.922B | 12.74 |
Insulet (PODD) | United States | $12.984B | 57.57 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
Haemonetics (HAE) | United States | $4.815B | 23.82 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Envista Holdings (NVST) | United States | $3.288B | 13.57 |
Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
Neogen (NEOG) | United States | $2.905B | 27.94 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
ICU Medical (ICUI) | United States | $2.589B | 22.85 |
Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
Warby Parker (WRBY) | United States | $1.600B | 0.00 |
InMode (INMD) | Israel | $1.565B | 8.32 |
Owens & Minor (OMI) | United States | $1.462B | 12.74 |
AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
AtriCure (ATRC) | United States | $1.077B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
Evolus (EOLS) | United States | $0.858B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
Quanterix (QTRX) | United States | $0.664B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
Valneva SE (VALN) | France | $0.614B | 0.00 |
PetIQ (PETQ) | United States | $0.583B | 19.05 |
TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
Jin Medical (ZJYL) | China | $0.507B | 0.00 |
Surmodics (SRDX) | United States | $0.486B | 30.43 |
ZimVie (ZIMV) | United States | $0.463B | 39.49 |
Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
Cerus (CERS) | United States | $0.362B | 0.00 |
Biote (BTMD) | United States | $0.362B | 8.34 |
Zynex (ZYXI) | United States | $0.350B | 47.83 |
MacroGenics (MGNX) | United States | $0.321B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
Veru (VERU) | United States | $0.201B | 0.00 |
Omeros (OMER) | United States | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
InterCure (INCR) | Israel | $0.143B | 24.19 |
Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
Fonar (FONR) | United States | $0.099B | 8.54 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Brainsway (BWAY) | Israel | $0.090B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.087B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
Safety Shot (SHOT) | United States | $0.074B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
Apyx Medical (APYX) | United States | $0.053B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 15.62 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |